Skip to main content
. 2021 Jul 9;111(4):359–367. doi: 10.1007/s00392-021-01903-1

Table 1.

Inclusion criteria

Inclusion criteria Subjects will only be included in the study if they meet all of the following criteria
Age ≥ 18 years
NYHA class II–IV symptoms (suspected cardiac dyspnea)
Systolic HF with a LVEF ≤ 35% or HF with preserved ejection fraction (NYHA class II–IV, elevated natriuretic peptides (NP), left ventricular hypertrophy (LVH) or left atrial enlargement (LAE) or diastolic dysfunction
BNP ≥ 100 pg/mL or NT proBNP ≥ 400 pg/mL
Subjects with the ability to follow study instructions and likely to attend and complete all required visits
Written informed consent